Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin.
LONDON – [7 th January 2025] – Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback